940865-65-6Relevant articles and documents
Improving the developability profile of pyrrolidine progesterone receptor partial agonists
Kallander, Lara S.,Washburn, David G.,Hoang, Tram H.,Frazee, James S.,Stoy, Patrick,Johnson, Latisha,Lu, Qing,Hammond, Marlys,Barton, Linda S.,Patterson, Jaclyn R.,Azzarano, Leonard M.,Nagilla, Rakesh,Madauss, Kevin P.,Williams, Shawn P.,Stewart, Eugene L.,Duraiswami, Chaya,Grygielko, Eugene T.,Xu, Xiaoping,Laping, Nicholas J.,Bray, Jeffrey D.,Thompson, Scott K.
scheme or table, p. 371 - 374 (2010/04/24)
The previously reported pyrrolidine class of progesterone receptor partial agonists demonstrated excellent potency but suffered from serious liabilities including hERG blockade and high volume of distribution in the rat. The basic pyrrolidine amine was in
PYRROLIDINEANILINES
-
Page/Page column 15, (2010/11/27)
The present invention relates to a compotind represented by the following formula I or a pharmaceutically acceptable salt thereof; wherein R1, R2, and y are defined herein. The present invention further relates to compositions that include the compound of the present invention as well as a method of treating a patient from endometreosis or uterine fibroids.